Details of the Drug Reposition

General Information of This Drug (ID: DM2IEB7)

Drug Name
Anti-CD30-CAR T cells   DM2IEB7
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Large cell lymphoma DISYZHCP 2A80.Z Phase 1 [1]
Lymphoma DISN6V4S 2A80-2A86 Phase 1 [1]
Hodgkin lymphoma DISX2OUL 2B30 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03049449) T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas